| 卵巢癌的肿瘤标记物测定与临床评价 |
| |
| 引用本文： | 延俊元,刘培淑,等. 卵巢癌的肿瘤标记物测定与临床评价[J]. 杭州医学高等专科学校学报, 2001, 22(1): 11-13 |
| |
| 作者姓名： | 延俊元 刘培淑 等 |
| |
| 作者单位： | [1]济南市第三人民医院，山东济南250012 [2]山东大学齐鲁医院，山东济南250012 |
| |
| 摘 要： | 目的 探讨肿瘤标记物在卵巢癌的诊断和预后判断方面的价值。方法 对1998年8月-1999年9月在山东大学齐鲁医院收治的45例卵巢肿瘤患者根据病理分类进行分组。回顾性分析克勤克俭 血清中AFP、CEA、Fepr、CA125、HCG、TSGF及SA水平，利用SAS统计分析系统分别评价6项肿瘤标记物在卵巢癌诊断和预后判断中的价值。结果 Fepr和SA对卵巢良恶性肿瘤的判别价值最大。但对不同病理类型鉴别价值不大。结论 Fepr和SA可以作为卵巢良恶性肿瘤的鉴别和恶性肿瘤预后判断的指标。
|
| 关 键 词： | 卵巢肿瘤 肿瘤标记物 临床评价 |
| 文章编号： | 1008-4894(2001)01-0011-03 |
The determination and clinical evaluation of tumor markers in the patients with ovarian tumor |
| |
| YAN Jun-yuan,LIU Pei-shu,SUN Li. The determination and clinical evaluation of tumor markers in the patients with ovarian tumor[J]. Journal of Hangzhou Medical College, 2001, 22(1): 11-13 |
| |
| Authors: | YAN Jun-yuan LIU Pei-shu SUN Li |
| |
| Abstract: | Objective To study the values of tumor markers in the diagnosis and prognosis of ovarian tumor.Method 45 cases of ovarian tumor are collected and divided into benign group and malignant group.The levels of turmor markers of the ases (including AFP, CEA, Fepr,CA 125 , HCG, TSGF and SA) are determined and analysed by T-test and ANOVA, and discrimination equations are founded by stepwise discrimination analysis.Result Fepr and SA have great values in distinguishing benign and malignant ovarian tumors, but they cannot distinguish the pathological types of the tumors.Conclusion Fepr and SA can be diagnosis indicators in distinguishing benign from malignant ovarian tumors. |
| |
| Keywords: | ovarian tumor tumor marker clinical evaluation |
| 本文献已被 CNKI 维普 等数据库收录！ |
